Lesson plan
D2-MDMA
d2-MDMA, also known as d2-3,4-methylenedioxymethamphetamine or as deuterated-MDMA (D-MDMA), is an entactogen and stimulant of the phenethylamine, amphetamine, and MDxx families related to MDMA ("ecstasy"). It is the deuterated isotopologue of MDMA in which the hydrogen atoms on the carbon atom of the 3,4-methylenedioxy ring have been replaced with the deuterium isotopes. MDMA is known to produce serotonergic neurotoxicity and associated cognitive deficits and emotional and behavioral changes. The neurotoxicity of MDMA may be due in part to metabolism of MDMA via opening of the 3,4-methylenedioxy ring or O-demethylation to form catechol metabolites like 3,4-dihydroxyamphetamine (HHA; α-methyldopamine) and 3,4-dihydroxymethamphetamine (HHMA; α,N-dimethyldopamine). These metabolites may subsequently undergo further metabolism into reactive oxygen species (ROS) that damage serotonergic neurons. In relation to this, d2-MDMA is thought to be more resistant to metabolism in this location due to the kinetic isotope effect, metabolically requiring a greater duration for relevant cytochrome P450 enzymes to break deuterium–carbon bonds compared to hydrogen–carbon bonds. As a result, d2-MDMA may have less neurotoxic potential than MDMA.…
Article summary
d2-MDMA, also known as d2-3,4-methylenedioxymethamphetamine or as deuterated-MDMA (D-MDMA), is an entactogen and stimulant of the phenethylamine, amphetamine, and MDxx families related to MDMA ("ecstasy"). It is the deuterated isotopologue of MDMA in which the hydrogen atoms on the carbon atom of the 3,4-methylenedioxy ring have been replaced with the deuterium isotopes. MDMA is known to produce serotonergic neurotoxicity and associated cognitive deficits and emotional and behavioral changes. The neurotoxicity of MDMA may be due in part to metabolism of MDMA via opening of the 3,4-methylenedioxy ring or O-demethylation to form catechol metabolites like 3,4-dihydroxyamphetamine (HHA; α-methyldopamine) and 3,4-dihydroxymethamphetamine (HHMA; α,N-dimethyldopamine). These metabolites may subsequently undergo further metabolism into reactive oxygen species (ROS) that damage serotonergic neurons. In relation to this, d2-MDMA is thought to be more resistant to metabolism in this location due to the kinetic isotope effect, metabolically requiring a greater duration for relevant cytochrome P450 enzymes to break deuterium–carbon bonds compared to hydrogen–carbon bonds. As a result, d2-MDMA may have less neurotoxic potential than MDMA.…
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.